These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 344115)

  • 1. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
    Turner RC; Holman RR
    Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal normoglycemia attained with chlorpropamide in mild diabetes.
    Holman RR; Turner RC
    Metabolism; 1978 May; 27(5):539-47. PubMed ID: 565457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
    Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
    J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
    Holman RR; Turner RC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):279-86. PubMed ID: 7021010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy.
    Clark A; Bown E; King T; Vanhegan RI; Turner RC
    Diabetes; 1982 Apr; 31(4 Pt 1):319-25. PubMed ID: 6759248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual beta-cell function in type II diabetes and evaluation of the hepatic insulin extraction.
    Toledo e Souza IT; Wajchenberg BL; Prestes Cesar F; Almeida Neto JS
    Horm Metab Res; 1983 Dec; 15(12):575-80. PubMed ID: 6363239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory B-cell activity in insulin dependent maturity-onset diabetic.
    Krause U; Faisst G; Cordes U; Beyer J
    Horm Metab Res; 1979 Apr; 11(4):261-5. PubMed ID: 378805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
    Turner RC; Holman RR; Matthews D; Hockaday TD; Peto J
    Metabolism; 1979 Nov; 28(11):1086-96. PubMed ID: 386029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes: The quest for basal normoglycaemia.
    Holman RR; Turner RC
    Lancet; 1977 Feb; 1(8009):469-74. PubMed ID: 65573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.
    Turner RC; Mathews DR; Holman RR; Peto J
    Lancet; 1982 Mar; 1(8272):596-8. PubMed ID: 6121186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
    Holman RR; Turner RC
    Diabetes; 1979 Mar; 28(3):227-30. PubMed ID: 446907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.